RedHill Biopharma's bowel syndrome drug succeeds in mid-stage study

(Reuters) - RedHill Biopharma Ltd said on Tuesday its drug to treat irritable bowel syndrome with diarrhea met the main goal in a mid-stage study.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news